Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9542319 | 0.94 | LMNA (0.78) | LMNABLMACE2PTPN1MEN1 | |
| SCHEMBL10866519 | 0.94 | LMNA (0.68) | LMNABLMACE2PTPN1MEN1 | |
| SCHEMBL110928 | 0.94 | LMNA (0.67) | LMNABLMACE2PTPN1MEN1 | |
| SCHEMBL2994810 | 0.92 | LMNA (0.63) | LMNABLMACE2PTPN1MEN1 | |
| SCHEMBL28724453 | 0.92 | LMNA (0.72) | LMNABLMACE2PTPN1MEN1 | |
| SCHEMBL149808 | 0.92 | LMNA (0.72) | LMNABLMACE2PTPN1MEN1 | |
| SCHEMBL2800953 | 0.92 | LMNA (0.63) | LMNABLMACE2PTPN1MEN1 | |
| SCHEMBL29843605 | 0.92 | LMNA (0.72) | LMNABLMACE2PTPN1MEN1 | |
| SCHEMBL1269942 | 0.92 | LMNA (0.72) | LMNABLMACE2PTPN1MEN1 | |
| SCHEMBL28224901 | 0.92 | LMNA (0.63) | LMNABLMACE2PTPN1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4264260-A1 | METHODS FOR DIAGNOSING CANCER BASED ON VOLATILE ORGANIC COMPOUNDS IN BLOOD AND URINE SAMPLES | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) | 2023-10-25 | — | — | EP | claimed |
| CN-113308221-B | Liquid adhesive wax | 深圳市科玺化工有限公司 | 2022-09-20 | — | — | CN | claimed |
| WO-2022137232-A1 | METHODS FOR DIAGNOSING CANCER BASED ON VOLATILE ORGANIC COMPOUNDS IN BLOOD AND URINE SAMPLES | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LIMITED (IL) | 2022-06-30 | — | — | WO | claimed |
| CN-113308221-A | Liquid adhesive wax | 深圳市科玺化工有限公司 | 2021-08-27 | — | — | CN | claimed |
| CN-112666288-A | Method for measuring volatile organic compounds in solid waste | 江苏微谱检测技术有限公司 | 2021-04-16 | — | — | CN | claimed |
| WO-2011048114-A1 | METHOD FOR THE DIFFERENTIATION BETWEEN CROHN'S DISEASE AND ULCERATIVE COLITIS BY DETECTING VOLATILE ORGANIC COMPOUNDS IN EXHALED AIR | UNIVERSITEIT MAASTRICHT (NL) | 2011-04-28 | — | — | WO | claimed |
| EP-2315029-A1 | Method for the differentiation between Crohn's disease and ulcerative colitis by detecting volatile organic compounds in exhaled air. | Universiteit Maastricht (NL) | 2011-04-27 | — | — | EP | claimed |
| US-20260079169-A1 | VOLATILE ORGANIC COMPOUNDS AS MARKERS FOR CELLULAR COMMUNICATION | TECHNION RES & DEV FOUNDATION (IL) | 2026-03-19 | — | — | US | disclosed |
| EP-4264260-A1 | METHODS FOR DIAGNOSING CANCER BASED ON VOLATILE ORGANIC COMPOUNDS IN BLOOD AND URINE SAMPLES | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) | 2023-10-25 | — | — | EP | disclosed |
| CN-113308221-B | Liquid adhesive wax | 深圳市科玺化工有限公司 | 2022-09-20 | — | — | CN | disclosed |
| WO-2022137232-A1 | METHODS FOR DIAGNOSING CANCER BASED ON VOLATILE ORGANIC COMPOUNDS IN BLOOD AND URINE SAMPLES | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LIMITED (IL) | 2022-06-30 | — | — | WO | disclosed |
| CN-114631607-A | Preparation method of fruit-flavored beverage and fruit-flavored beverage | 西南大学 | 2022-06-17 | — | — | CN | disclosed |
| CN-113308221-A | Liquid adhesive wax | 深圳市科玺化工有限公司 | 2021-08-27 | — | — | CN | disclosed |
| EP-2315029-A1 | Method for the differentiation between Crohn's disease and ulcerative colitis by detecting volatile organic compounds in exhaled air. | Universiteit Maastricht (NL) | 2011-04-27 | — | — | EP | disclosed |
| US-20110046422-A1 | FUEL COMPOSITIONS COMPRISING ISOPRENE DERIVATIVES | DANISCO US INC. | 2011-02-24 | — | — | US | disclosed |
| WO-2010148256-A1 | FUEL COMPOSITIONS COMPRISING ISOPRENE DERIVATIVES | DANISCO US INC. (US) | 2010-12-23 | — | — | WO | disclosed |
| US-20080009099-A1 | System and method of monitoring contamination | ENTEGRIS, INC. | 2008-01-10 | — | — | US | disclosed |
| CN-1289171-C | System and method for monitoring contamination | EXTRACTION SYSTEMS INC (US) | 2006-12-13 | — | — | CN | disclosed |
| CN-1575194-A | System and method for monitoring contamination | EXTRACTION SYSTEMS INC (US) | 2005-02-02 | — | — | CN | disclosed |
| US-6759254-B2 | System and method for determining and controlling contamination | EXTRACTION SYSTEMS, INC. | 2004-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260079169-A1 | VOLATILE ORGANIC COMPOUNDS AS MARKERS FOR CELLULAR COMMUNICATION | BCL2, BAX, EPCAM | LMNA 1718/4885BLM 4024/4885ACE2 4419/4885 |
| US-20110046422-A1 | FUEL COMPOSITIONS COMPRISING ISOPRENE DERIVATIVES | GGPS1, FNTA, COASY | LMNA 1811/4885BLM 409/4885ACE2 2165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.